Peri-Implantitis & Signs of Dental Implant Failure

Dental implant failure is generally split into two categories defined by timing and cause. Early implant failure occurs before or shortly after the implant is brought into function, and is typically attributed to a failure of osseointegration itself — the implant never fully anchors into the surrounding bone. A 2011 review of implant failure etiology identifies the leading causes here as surgical or biological: a lack of primary mechanical stability at the moment of placement, surgical trauma, or infection introduced around the time of surgery (Sakka & Coulthard, 2011). A retrospective comparison of early and late implant failures found that early failures were more often linked to implants placed to support single crowns and occurred with minimal bone loss at the time they were identified (Manor et al., 2009).

Late implant failure occurs after an implant has already achieved successful osseointegration and been in function, sometimes for years. Here, peri-implantitis is the dominant driver: it is a progressive, infection-associated condition that destroys the bone anchoring an implant that had previously integrated successfully — peri-implantitis causes dental implant failure by this mechanism specifically, rather than by preventing integration from ever occurring in the first place. Occlusal overload — excessive or uneven biting force on the implant over time — is a separate, non-infectious contributor to late failure identified in the same literature.

These two categories also help put the headline survival numbers in context. A systematic review and sensitivity meta-analysis of eighteen prospective studies found a pooled ten-year implant survival rate of 96.4% (95% CI 95.2-97.5%) (Howe et al., 2019, Journal of Dentistry). Separately, a systematic review of peri-implant disease epidemiology found a weighted mean peri-implantitis prevalence of 22% (95% CI 14-30%), and a weighted mean peri-implant mucositis prevalence of 43% (95% CI 32-54%) (Derks & Tomasi, 2015, Journal of Clinical Periodontology) — figures corroborated by a second, larger systematic review reporting 19.53% patient-level peri-implantitis prevalence (Diaz et al., 2022, BMC Oral Health). Read together, these numbers indicate that most implants that survive their initial healing period remain in place at ten years, but a meaningful minority develop peri-implant disease along the way — which is why the late, disease-driven category is where most of the ongoing clinical attention in this field is concentrated, rather than early surgical failure.

The clinical case definition for peri-implantitis, set out in a 2018 consensus report, combines bleeding on probing and/or suppuration on gentle probing with radiographic evidence of progressive bone loss beyond expected early remodelling, and an increase in probing depth compared with earlier baseline measurements; where no baseline record exists, the same report uses marginal bone loss greater than 3mm and probing depth greater than 6mm as reference points (Renvert et al., 2018, Journal of Clinical Periodontology). This matters for how a patient should read early symptoms: bleeding, redness, or swelling around an implant is also consistent with peri-implant mucositis, a milder and earlier inflammatory stage confined to the soft tissue that has not yet involved bone loss. Bleeding gums around an implant, in other words, do not automatically mean bone loss has started — the distinction is made using probing depth and radiographic findings, not visible inflammation alone.

Implant mobility is a different signal entirely. Unlike a natural tooth, which has a small amount of physiological movement from its periodontal ligament, a successfully osseointegrated implant should show essentially no mobility. A review of implant failure etiology states plainly that mobility resulting from total loss of osseointegration necessitates removal of the implant (Sakka & Coulthard, 2011). Mobility is, for this reason, considered a late and serious sign rather than an early one: enough surrounding bone loss has to accumulate first to loosen the fixture, so by the time mobility is clinically detectable, the underlying bone loss is typically already advanced.

Pain follows a similarly counter-intuitive pattern. Peri-implantitis, much like periodontal disease around natural teeth, is frequently painless in its earlier stages, because bone loss and pocket formation around the implant do not necessarily produce significant discomfort on their own. This is exactly why bleeding, swelling, and probing or imaging findings picked up at a routine review visit — rather than pain reported by the patient — are what the diagnostic criteria above rely on to catch the condition before mobility develops. When pain does occur, it is more often tied to an acute infection or abscess, or to a mechanical complication such as a loose component, than to the underlying bone-loss process itself.

Bacterial plaque is the proximate trigger behind this entire disease process. Just as with periodontal disease around natural teeth, an accumulation of bacterial biofilm on the implant surface and the surrounding tissue initiates the inflammatory response that defines peri-implant mucositis and, if it is not addressed, progresses into the bone loss that defines peri-implantitis. The 2018 consensus case definitions build both conditions around this same plaque-driven inflammatory process (Renvert et al., 2018), which is why plaque control and regular professional review are the primary preventive measures pointed to across this literature.

Smoking is one of the more heavily studied risk factors. A 2024 systematic review and meta-analysis pooling 32 observational studies — 59,246 implants and 14,115 patients across studies published between 1994 and 2024 — found that smoking was associated with roughly 2.6 times higher odds of early implant failure compared with non-smoking at the implant level (odds ratio 2.59, 95% CI 2.08-3.23), with a larger relative increase specifically at maxillary sites (odds ratio 5.90) than at mandibular sites (odds ratio 3.76) in the subset of studies reporting site-specific data (Fan et al., 2024, Journal of Dentistry). The proposed mechanisms in this literature include impaired blood supply and angiogenesis at the healing implant site, an altered oral microbiome, and a heightened local inflammatory response — smoking increases the risk of implant failure through these pathways rather than through any single cause.

Diabetes mellitus shows a comparable pattern. A 2022 systematic review and meta-analysis pooling 89 publications — 5,510 implants placed in patients with diabetes against 62,780 implants in patients without — found implants in patients with diabetes carried roughly 1.8 times higher odds of failure than implants in patients without diabetes (odds ratio 1.777), with a larger disparity where type 1 diabetes specifically was compared with type 2 (odds ratio 4.477) (Al Ansari et al., 2022, Materials). Some of the studies included in that body of literature point toward glycaemic control, rather than a diabetes diagnosis in isolation, as the more clinically relevant variable — though the pooled analysis itself compared diabetic and non-diabetic groups as a whole rather than stratifying results by blood-glucose control level.

Oral hygiene is the modifiable factor patients have the most direct influence over, since accumulated plaque is the trigger described at the start of this section. Poor oral hygiene is consistently identified alongside smoking and diabetes as a patient-level risk factor across the peri-implant disease literature (Renvert et al., 2018; Derks & Tomasi, 2015). No single, defensible population-wide percentage quantifying how much hygiene changes an individual's risk was found in this research pass, so this page describes the mechanism — plaque triggering the same inflammatory-then-bone-loss process outlined above — rather than attaching an unsupported number to it.

Once peri-implantitis is diagnosed, initial treatment is generally non-surgical: mechanical and chemical decontamination of the implant surface, aimed at disrupting the bacterial biofilm and resolving the inflammatory component of the disease. A 2024 review of surgical treatment for peri-implantitis notes that non-surgical approaches on their own have shown limited effectiveness once bone loss and deeper pockets are already established, which is why surgical treatment becomes the primary approach once the condition has progressed (Roccuzzo et al., 2024, British Dental Journal).

That same review describes two broad surgical categories. Access flap debridement, sometimes combined with resective procedures that reshape the surrounding bone and the implant surface — including implantoplasty, which mechanically smooths the exposed, contaminated implant threads to make the surface less able to retain plaque, at the recognised cost of some mucosal recession as a trade-off. The alternative is reconstructive or regenerative surgery, which attempts to graft the bone defect around the implant and encourage re-osseointegration where the defect's shape allows it. Neither approach is presented in this literature as reliably restoring the implant to its original state; the choice between them depends on the specific shape and depth of the bone defect around that particular implant.

Where bone loss is too advanced, or where implant mobility has already appeared — indicating, per the mechanism described above, a substantial or total loss of osseointegration — remediation generally shifts from an attempt to save the implant to removing it (explantation), managing the resulting bone defect, and considering whether the site could support a replacement implant later, sometimes after its own bone-grafting healing interval. It bears repeating plainly that revision surgery is a treatment attempt on a diseased implant, not an assurance that the implant will remain stable afterward.

Because pain is often absent until late in the disease process, and mobility is itself already a late-stage sign by the time it appears, the signs worth acting on earlier are the ones described above: bleeding when brushing or flossing around an implant, visible redness or swelling of the gum at the implant site, any pus or discharge, a noticeable change in how the crown or prosthesis feels when biting, or any perceptible looseness. Routine professional review — rather than waiting for a symptom to show up — is what the diagnostic approach described earlier in this article is built around, precisely because it can catch bleeding-on-probing and probing-depth changes at an earlier, more manageable stage than a patient is likely to notice on their own.

Only a dentist can distinguish reversible peri-implant mucositis from the bone loss that defines peri-implantitis, since that distinction rests on probing depth measurements and radiographic imaging rather than anything visible to the patient. The practical takeaway is that any of the signs above, even if mild or intermittent, is a reasonable reason to book a review rather than to wait for them to resolve on their own or to worsen.